Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia
A phase 3 trial of Magrolimab, Venetoclax and Azacitidine in Acute myeloid leukaemia, run by Gilead Sciences, recorded as terminated on the registry.
Overview
Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia is a phase 3 interventional study registered as NCT05079230 by Gilead Sciences, with 378 participants recorded, started 2022-07-07 and due to reach its primary completion in 2024-04-11. Interventions recorded: Magrolimab, Venetoclax, Azacitidine, Placebo. Conditions recorded: Acute Myeloid Leukemia.
Linked to the drug Magrolimab because the registry names it among its interventions and Acute myeloid leukaemia among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialMagrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)
Shares Magrolimab, Gilead Sciences (incl. Kite), Azacitidine and the tag pipeline.
- TrialStudy of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated
Shares Magrolimab, Gilead Sciences (incl. Kite), Azacitidine, Venetoclax and the tag pipeline.
- TrialStudy of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome
Shares Azacitidine, Venetoclax, Acute myeloid leukaemia and the tag pipeline.
- TrialStudy to Evaluate the Safety and Tolerability of EP0042
Shares Azacitidine, Venetoclax, Acute myeloid leukaemia and the tag pipeline.
- TrialA Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies
Shares Azacitidine, Venetoclax, Acute myeloid leukaemia and the tag pipeline.
- TrialA Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia
Shares Azacitidine, Venetoclax, Acute myeloid leukaemia and the tag pipeline.
- TrialGalinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
Shares Azacitidine, Venetoclax, Acute myeloid leukaemia and the tag pipeline.
- TrialStudy of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients
Shares Azacitidine, Venetoclax, Acute myeloid leukaemia and the tag pipeline.